Because of the recent public disgust over withdrawn drugs, the FDA is proposing closer government scrutiny of new drugs. The pilot program will issue drug “report cards” that would detail unexpected side effects that emerge during the first 18 months following the drug’s approval. The report cards will also record how the drug is being used. This aspect of the proposal will be a big improvement in light of the recent issues of drug companies marketing their drugs for unapproved uses.
For the full article.